Fluid Requirement During Surgery PVI v Doppler

NCT ID: NCT02142816

Last Updated: 2014-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Targeting the amount of fluid given to measurements of the patients own fluid status during major abdominal surgery has been linked with improved speed of recovery of gut function and reduced length of hospital stay, mortality and complications.

Pleth variability index (PVI) offers a noninvasive, risk and pain free alternative to more invasive forms of monitoring to direct how much fluid to give.

The study aims primarily to measure and compare how much fluid is given when guided by PVI compared to the established technique; oesophageal doppler during major abdominal surgery.

The study will compare 40 patients undergoing major elective abdominal surgery. Patients will receive intraoperative fluid guided by either oesophageal doppler or PVI. Secondarily, the study will examine biochemical markers, length of hospital stay and how frequently complications occur

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Surgery Major Abdominal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Doppler

Fluid directed by oesophageal doppler

Group Type ACTIVE_COMPARATOR

Doppler

Intervention Type DEVICE

Fluid therapy guided by doppler

PVI

Fluid therapy directed by Pleth Variability Index

Group Type ACTIVE_COMPARATOR

PVI'

Intervention Type OTHER

Fluid therapy guided by PVI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Doppler

Fluid therapy guided by doppler

Intervention Type DEVICE

PVI'

Fluid therapy guided by PVI

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major abdominal surgery
* Anaerobic Threshold \>11 ml O2/kg/min
* VE/VCO2 \<34 OR
* Low risk according to Consultant anaesthetist

Exclusion Criteria

* Patients age less than 18
* Patient refused consent
* Patient unable to give consent
* Patient has had \<24hrs to consider the Patient information Sheet
* Contraindication to Doppler Probe being inserted
* Emergency Procedure
* Patient has a ASA Grade 5
* Patient is receiving dialysis treatment
* Patient has a known hypersensitivity to hydroxyethyl starch or gelatin solutions
* Patients with renal failure with oliguria or anuria - not related to hypovolaemia
* Patients with a previously diagnosed dysrhythmia
* Patients who weight \>100kg
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

York Teaching Hospitals NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Yates, MB ChB

Role: PRINCIPAL_INVESTIGATOR

York Teaching Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

York Teaching Hospital

York, N Yorks, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

YOR-A02089

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.